These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3410034)

  • 1. [Effect of benzonal on the drug-metabolizing function of the liver in pathological states].
    Nadzhimutdinov KN; Khakimov ZZ
    Farmakol Toksikol; 1988; 51(3):72-5. PubMed ID: 3410034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and experimental research on the drug-metabolizing function of the liver in peritonitis].
    Khakimov ZZ; Nadzhimutdinov KN; Akhmedov RM
    Farmakol Toksikol; 1988; 51(2):80-2. PubMed ID: 3378613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vivo activity of drug-metabolizing enzymes in various pathological conditions].
    Krakovskiĭ ME; Ashirmetov AKh
    Vopr Med Khim; 1985; 31(1):76-9. PubMed ID: 3984279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of metabolic efficiency of the liver in patients with psoriasis by the antipyrine test].
    Bienias L; Czarnecki M; Kaszuba A; Ruszczak Z; Kozłowska M; Bednarowicz G; Drobnik G
    Przegl Dermatol; 1990; 77(5):301-6. PubMed ID: 2270292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of phytin, benzonal and their combination administered prophylactically on the pharmacodynamics of drugs metabolized in the liver in hypokinesia].
    Khakimov ZZ; Mavlianov BR; Rakhmanov AKh; Mavlianov IR
    Eksp Klin Farmakol; 1992; 55(6):58-60. PubMed ID: 1305882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological characteristics of an anti-convulsive drug Benzonal and the evaluation of its therapeutic effectiveness (review of the literature)].
    Okudzhava VM; Chankvetadze BG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(11):136-45. PubMed ID: 2696306
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness of cytochrome P-450 inducer Benzonal in the treatment of acute hepatitis].
    Makhmudov OS; Khakimov ZZ; Tsipkina SV; Pashutina IV
    Klin Med (Mosk); 1989 Nov; 67(11):62-5. PubMed ID: 2625963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenazone as a marker of liver-metabolic function in patients with acute leukemia.
    Wiela-Hojenska A; Orzechowska-Juzwenko K; Usnarska-Zubkiewicz L; Kotlarek-Haus S; Hurkacz M
    Int J Clin Pharmacol Ther; 1999 May; 37(5):234-7. PubMed ID: 10363621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of antipyrine in viral and alcoholic lesions of the liver].
    Tsyrkunov VM; Bushma MI; Garelik PV; Novitskiĭ GK; Zavodnik LB
    Klin Med (Mosk); 1989 Feb; 67(2):87-9. PubMed ID: 2724896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detoxification function of the liver and body resistance in patients with acute intestinal obstruction].
    Razzakov SM; Krakovskiĭ ME; Ashirmetov AKh
    Khirurgiia (Mosk); 1990 Dec; (12):11-5. PubMed ID: 2079783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the capacity of the liver for phenazone biotransformation in patients with uremia on peritoneal dialysis].
    Grzegorzewska A; Lowicki Z; Chmara E; Mrozikiewicz A; Baczyk K
    Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):339-41. PubMed ID: 2235722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The liver monooxygenase system activity in the long-term compression syndrome and treatment with benzonal in prepubertal rats and rabbits].
    Rakhmatullaev FKh; Khakimov ZZ
    Eksp Klin Farmakol; 2001; 64(2):69-71. PubMed ID: 11548454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The antipyrine test in occupational medicine research--evaluation of individual reproducibility and frequency distribution of half-life].
    Uhlig H; Damrau J; Skölziger R
    Z Gesamte Hyg; 1989 Feb; 35(2):82-4. PubMed ID: 2741499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oxidative hepatic metabolism in chronic alcoholics during the acute abstinence period: evaluation with antipyrine elimination].
    Soto Alvarez J; Alsar Ortiz MJ
    Rev Clin Esp; 1993 Jun; 193(2):60-3. PubMed ID: 8341815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of estrogens on pharmacokinetics of phenazone and N-acetyl-p-aminophenol].
    Kwiatkowski A
    Ann Acad Med Stetin; 1991; 37():35-47. PubMed ID: 1816754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antipyrine test in evaluation of the functional state of the liver in the postoperative period].
    Nadzhimutdinov KN; Krakovskiĭ ME; Ashirmetov AKh; Komarin AS; Kaiumov TKh
    Khirurgiia (Mosk); 1986 Feb; (2):21-3. PubMed ID: 3959450
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic functions of the liver during chemotherapy in children with acute lymphoblastic leukemia.
    Wiela-Hojenska A; Gorczynska E; Orzechowska-Juzwenko K; Golebiowski W; Hurkacz M; Boguslawska-Jaworska J
    Int J Clin Pharmacol Ther; 2001 Jun; 39(6):246-50. PubMed ID: 11430632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antipyrine test in the diagnosis of chronic cholecystitis].
    Gorchakova LA; Dynnik OB; Poddubnyĭ NM; Romanenko VA; Taranenko NB; Prokhorenko OA
    Klin Med (Mosk); 1989 Nov; 67(11):65-7. PubMed ID: 2625964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.